Control-patients (N = 30) | Obese patients | |||
---|---|---|---|---|
NT (N = 20) | Pre-HT (N = 20) | HT (N = 20) | ||
Age (years) | 14.5 ± 1.5 | 13.8 ± 0.9 | 14.7 ± 1.6 | 15.1 ± 1.1 |
Gender (M/F) | 18/12 | 9/11 | 9/11 | 9/11 |
Diastolic BP (mmHg) | 72. 5 ± 5.2 | 80.3 ± 2.1* | 83.1 ± 2.5* | 87.3 ± 2.6*, # a |
Systolic BP (mmHg) | 114 ± 6.1 | 117.5 ± 3.4 | 128.1 ± 3.9*, # | 147 ± 6.5*, #, a |
BMI | 21.2 ± 1.2 | 32.9 ± 0.5* | 32.2 ± 0.7* | 33.6 ± 0.6* |
Glucose (mg/dl) | 78.2 ± 4.7 | 105.4 ± 3.3* | 113.6 ± 1.8*, # | 125.6 ± 5.3*,#, a |
Insulin (µIU/ml) | 5.5 ± 0.7 | 8.5 ± 0.4* | 10.5 ± 1.5*, # | 13.5 ± 0.7*, #, a |
HOMA-index | 1.1 ± 0.1 | 2.2 ± 0.03* | 2.9 ± 0.06* | 4.1 ± 0.09*, #, a |
TG (mg/dl) | 75.8 ± 10.4 | 198.7 ± 19.7* | 206.5 ± 28.9* | 215.9 ± 22.5* |
TC (mg/dl) | 132.1 ± 7.2 | 289.2 ± 16.7* | 299.2 ± 30.7* | 312.5 ± 21*, # |
LDL-C (mg/dl) | 77.2 ± 4.7 | 199.6 ± 12.8* | 208. 5 ± 23.9* | 218.9 ± 13.7*, # |
HDL-C (mg/dl) | 39.73 ± 3.5 | 49.75 ± 3.8* | 49.46 ± 4.1* | 50.53 ± 3.8* |
Metabolic syndrome | No | No | Yes | Yes |